MORGAN BOWLER: Open Payments
NPI 1447390315 · CANTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,899 in 127 payments from 37 companies in 2025. Trend: 2023 $1,367 · 2024 $2,355 · 2025 $2,899
Food & beverage: $2,886Education: $13
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $301 |
| AstraZeneca Pharmaceuticals LP | 10 | $280 |
| Novartis Pharmaceuticals Corporation | 12 | $244 |
| Merck Sharp & Dohme LLC | 5 | $155 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $131 |
| Genentech USA, Inc. | 6 | $118 |
| Celgene Corporation | 5 | $110 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $105 |
| ABBVIE INC. | 5 | $105 |
| ARRAY BIOPHARMA INC | 9 | $102 |
Products named: IBRANCE, ENHERTU, REBLOZYL, Nubeqa, BRUKINSA, SCEMBLIX, WELIREG, VENCLEXTA.
Industry payments across GA — which companies pay providers there.
